Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities

Objective: This study aimed to determine the association between hyperuricemia, comorbid diseases and risk of developing gout disease in a Turkish population in a long follow-up period. Methods: A total of 2000 Turkish adults were cross-sectionally analysed for serum urate levels in 2009 at the Pamu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Firdevs Ulutaş, Aslı Bozdemir, Nevzat Atalay Çelikyürek, Canan Albayrak Yaşar, Veli Çobankara
Formato: article
Lenguaje:EN
Publicado: PCO Convin S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/0f529d927b3e42e8ac44f9d3a60251e0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0f529d927b3e42e8ac44f9d3a60251e0
record_format dspace
spelling oai:doaj.org-article:0f529d927b3e42e8ac44f9d3a60251e02021-11-08T08:28:47ZCut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities2529-198X10.31138/mjr.32.3.243https://doaj.org/article/0f529d927b3e42e8ac44f9d3a60251e02021-01-01T00:00:00Zhttp://www.mjrheum.org/assets/files/792/file332_1358.pdfhttps://doaj.org/toc/2529-198XObjective: This study aimed to determine the association between hyperuricemia, comorbid diseases and risk of developing gout disease in a Turkish population in a long follow-up period. Methods: A total of 2000 Turkish adults were cross-sectionally analysed for serum urate levels in 2009 at the Pamukkale University Faculty of Medicine. All patients on regular follow-up at our tertiary health center (n=1322) were included in this study. Demographic features (age and gender), comorbid clinical conditions, and medication use were noted. The risk of developing gout and the determinant factors were investigated. Multivariate logistic regression analysis was performed to analyse causative effects of factors while receiver operating characteristic (ROC) curve analysis was used to identify optimal cut-off values of uric acid level for predicting the development of gout. Results: Among 1322 patients, the mean age was 56.9 (SD:14.68) years. 57.3% (n=758) of the patients were female. The most common co-morbid disease was chronic kidney disease (581, 43%), followed by hypertension (522, 39.4%). Gout developed in 25 patients (1.8%). Gout development risk and presence of all the above comorbidities were significantly higher in patients with serum urate ≥7mg/dl compared with <7mg/dl. Male gender and not using urate lowering drugs were the main risk factors for developing gout disease. ROC analysis of serum uric acid levels identified a cut-off value of >7 (AUC: 0.776, sensitivity 86.96%, specificity 66.74%). Conclusion: There is still a dilemma concerning the culprit effects of both comorbidities and hyperuricemia on the risk of developing gout disease.Firdevs UlutaşAslı BozdemirNevzat Atalay ÇelikyürekCanan Albayrak YaşarVeli ÇobankaraPCO Convin S.A.articlehyperuricemiagoutco-morbid diseasecut-offDiseases of the musculoskeletal systemRC925-935ENMediterranean Journal of Rheumatology, Vol 32, Iss 3, Pp 243-248 (2021)
institution DOAJ
collection DOAJ
language EN
topic hyperuricemia
gout
co-morbid disease
cut-off
Diseases of the musculoskeletal system
RC925-935
spellingShingle hyperuricemia
gout
co-morbid disease
cut-off
Diseases of the musculoskeletal system
RC925-935
Firdevs Ulutaş
Aslı Bozdemir
Nevzat Atalay Çelikyürek
Canan Albayrak Yaşar
Veli Çobankara
Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities
description Objective: This study aimed to determine the association between hyperuricemia, comorbid diseases and risk of developing gout disease in a Turkish population in a long follow-up period. Methods: A total of 2000 Turkish adults were cross-sectionally analysed for serum urate levels in 2009 at the Pamukkale University Faculty of Medicine. All patients on regular follow-up at our tertiary health center (n=1322) were included in this study. Demographic features (age and gender), comorbid clinical conditions, and medication use were noted. The risk of developing gout and the determinant factors were investigated. Multivariate logistic regression analysis was performed to analyse causative effects of factors while receiver operating characteristic (ROC) curve analysis was used to identify optimal cut-off values of uric acid level for predicting the development of gout. Results: Among 1322 patients, the mean age was 56.9 (SD:14.68) years. 57.3% (n=758) of the patients were female. The most common co-morbid disease was chronic kidney disease (581, 43%), followed by hypertension (522, 39.4%). Gout developed in 25 patients (1.8%). Gout development risk and presence of all the above comorbidities were significantly higher in patients with serum urate ≥7mg/dl compared with <7mg/dl. Male gender and not using urate lowering drugs were the main risk factors for developing gout disease. ROC analysis of serum uric acid levels identified a cut-off value of >7 (AUC: 0.776, sensitivity 86.96%, specificity 66.74%). Conclusion: There is still a dilemma concerning the culprit effects of both comorbidities and hyperuricemia on the risk of developing gout disease.
format article
author Firdevs Ulutaş
Aslı Bozdemir
Nevzat Atalay Çelikyürek
Canan Albayrak Yaşar
Veli Çobankara
author_facet Firdevs Ulutaş
Aslı Bozdemir
Nevzat Atalay Çelikyürek
Canan Albayrak Yaşar
Veli Çobankara
author_sort Firdevs Ulutaş
title Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities
title_short Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities
title_full Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities
title_fullStr Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities
title_full_unstemmed Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities
title_sort cut-off value of serum uric acid for development of gout disease in patients with multiple co-morbidities
publisher PCO Convin S.A.
publishDate 2021
url https://doaj.org/article/0f529d927b3e42e8ac44f9d3a60251e0
work_keys_str_mv AT firdevsulutas cutoffvalueofserumuricacidfordevelopmentofgoutdiseaseinpatientswithmultiplecomorbidities
AT aslıbozdemir cutoffvalueofserumuricacidfordevelopmentofgoutdiseaseinpatientswithmultiplecomorbidities
AT nevzatatalaycelikyurek cutoffvalueofserumuricacidfordevelopmentofgoutdiseaseinpatientswithmultiplecomorbidities
AT cananalbayrakyasar cutoffvalueofserumuricacidfordevelopmentofgoutdiseaseinpatientswithmultiplecomorbidities
AT velicobankara cutoffvalueofserumuricacidfordevelopmentofgoutdiseaseinpatientswithmultiplecomorbidities
_version_ 1718442683197816832